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Don’t We Understand?*
John McB. Hodgson, MDP hysiologists and physicians have long beeninterested in blood ﬂow and pressure (i.e.,hemodynamics). The importance of the circu-
latory system in regulating health and disease has
been appreciated since the days of blood-letting
and leaches. In 1738, Daniel Bernoulli (1) elegantly
described the impact of narrowings on pressure and
ﬂow in his book Hydrodynamica. The principles he
described then are still accurate today and underpin
our current physiologic measurements. In the mid-
19th century, Volkmann (2) was recording arterial
pressure waveforms in animals. The importance of
translesional gradients was appreciated by Andreas
Grünzig (3) from the ﬁrst percutaneous coronary
intervention (PCI). Even using crude measurement
techniques, it was possible to show patient beneﬁt
when gradients were low post PCI (4). And, in the
early 1990s, Nico Pijls et al. (5) validated a lesion
speciﬁc, simple to use measure to determine the phys-
iologic signiﬁcance of individual coronary lesions:
fractional ﬂow reserve (FFR).SEE PAGE 1641In this issue of the Journal, Johnson et al. (6) (with
authors from more than 30 institutions) have pro-
vided an elegant analysis of FFR data collected over
the past 20 years. Using meta-analysis techniques,
they have shown a continuous relationship between
measured FFR and patient outcome. Although the*Editorials published in the Journal of the American College of Cardiology
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InfraRedX.statistics may be a bit daunting for the average
clinician (myself included), the message is quite
clear: When FFR values are low, patients beneﬁt from
revascularization and when FFR values are high, we
can do harm by proceeding with revascularization.
Reassuringly, the optimal “cut-point” for deter-
mining revascularization strategy using this statisti-
cal analysis remains in the 0.75 to 0.80 range. In the
age of medical cost containment, a technique that is
both less costly and more effective is a rarity. FFR is
one such technique (7–10). The current meta-analysis
determined that an FFR-guided revascularization
strategy (as opposed to an angiographically guided
strategy) was associated with a 50% reduction in
PCI, while resulting in 10% better angina relief
with 20% fewer adverse events. Finally, the results
were consistent in 3 important subgroups: left main
lesions, diabetic patients, and acute coronary syn-
drome patients.
At least 3 prior studies have demonstrated that an
FFR-guided approach offers patient beneﬁt. The
DEFER trial was performed in the early 2000s. Defer-
ring intervention when FFR was not abnormal led to
better outcomes than performing PCI (11). In 2005,
Legalery et al. (12) showed that compliance with FFR-
indicated therapy resulted in improved outcomes. In
2009, The FAME (Fractional Flow Reserve Versus
Angiography for Multivessel Evaluation) trial results
were published and widely acknowledged by the
interventional community (13). This randomized trial
demonstrated signiﬁcantly better outcomes when PCI
was guided by FFR. Unfortunately, these trials failed
to alter the clinical practice of most cardiologists.
Figure 1 shows the rate of FFR use during catheteri-
zation procedures in U.S. Medicare beneﬁciaries.
Although there was an uptick in FFR use in 2009
following publication of the FAME trial data, as of 2012
the percent of diagnostic catheterizations having FFR
performed remained a paltry 4%.
16%
14%
12%
10%
8%
6%
4%
2%
0%
2005 2006 2007 2008 2009
Year
Pe
rc
en
ta
ge
 o
f C
as
es
2010 2011 2012
2005 2006 2007 2008 2009 2010 2011 2012
1.5% 1.9% 2.4% 3.1% 3.1% 6.3% 8.2% 11.0%
3.9%2.7%2.1%1.0%1.0%0.8%0.7%0.5%
FFR/PCI
FFR/Diag Cath
FIGURE 1 FFR Utilization Trend From 2005 to 2012 in the United States
Percent of diagnostic catheterizations (Diag Cath) (red line) and percutaneous coronary
interventional (PCI) (slate line) procedures that also had fractional ﬂow reserve (FFR)
performed at the same setting. Data are abstracted from public records detailing
procedures performed in U.S. Medicare beneﬁciaries.
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1656For more than 10 years, as data have been pub-
lished, the importance of routinely performing FFR
has been emphasized in review articles and edito-
rials (14–17). FFR guidance has been shown to be of
value in intermediate lesions (5,18), side branches(19,20), left main lesions (21,22), potential bypass
graft insertion sites (23,24), and in-stent restenosis
lesions (25) to name a few unique applications. An
FFR-based interventional strategy has been shown
to improve patient outcomes in balloon angioplasty
(26), in bare-metal stent PCI (27), in drug-eluting
stent PCI (28,29), and in guiding surgical revascu-
larization (23,24,30). The pressure sensor wires are
easy to use, the procedure is simple and reproducible,
and the FFR strategy is highly cost-effective. Scien-
tiﬁc statements speciﬁcally devoted to physiologic
measures in the catheterization laboratory have been
written (31). The multisociety PCI guidelines give FFR
a Class IIa indication (32) and the appropriate use
criteria for both diagnostic catheterization and
revascularization include FFR for any intermediate
lesion not already having corresponding non-invasive
evidence of stress induced ischemia (33,34). So, one is
left wondering what part of the FFR link don’t inter-
ventional cardiologists understand? The data are
clear; the cardiology community should not tolerate
continuing to ignore it.
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